UNICA IRIS Institutional Research Information System

ZUDDAS, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 104.318
NA - Nord America 9.164
AS - Asia 3.317
SA - Sud America 578
AF - Africa 54
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 3
Totale 117.466
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 100.507
US - Stati Uniti d'America 9.027
SG - Singapore 1.338
CN - Cina 1.337
NL - Olanda 1.132
UA - Ucraina 750
SE - Svezia 547
BR - Brasile 509
GB - Regno Unito 363
DE - Germania 317
FR - Francia 248
FI - Finlandia 209
VN - Vietnam 181
HK - Hong Kong 114
CA - Canada 78
KR - Corea 74
IN - India 67
RU - Federazione Russa 45
AU - Australia 31
AT - Austria 30
TR - Turchia 29
AR - Argentina 26
ES - Italia 26
MX - Messico 26
BD - Bangladesh 23
ZA - Sudafrica 22
CH - Svizzera 19
PL - Polonia 18
BE - Belgio 17
IQ - Iraq 17
AE - Emirati Arabi Uniti 15
EC - Ecuador 15
SA - Arabia Saudita 15
ID - Indonesia 13
IL - Israele 13
MA - Marocco 13
DK - Danimarca 12
IR - Iran 12
PK - Pakistan 12
JP - Giappone 11
NO - Norvegia 10
RO - Romania 10
CR - Costa Rica 9
IE - Irlanda 9
JO - Giordania 9
GR - Grecia 8
UZ - Uzbekistan 8
CO - Colombia 7
LT - Lituania 7
VE - Venezuela 7
DO - Repubblica Dominicana 6
HN - Honduras 6
PT - Portogallo 6
KZ - Kazakistan 5
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
EG - Egitto 4
JM - Giamaica 4
MY - Malesia 4
PH - Filippine 4
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
GT - Guatemala 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
DZ - Algeria 2
KE - Kenya 2
MD - Moldavia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
SI - Slovenia 2
SM - San Marino 2
AO - Angola 1
BH - Bahrain 1
BZ - Belize 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
Totale 117.463
Salva come PNG Salva come JPEG
Città #
Cagliari 92.613
Uta 5.293
Amsterdam 1.066
Fairfield 921
Woodbridge 846
Ashburn 709
Singapore 641
Chandler 596
Houston 573
Boardman 566
Ann Arbor 444
Dallas 416
Jacksonville 390
Wilmington 384
Seattle 357
Nyköping 340
Cambridge 293
Beijing 274
Milan 244
Rome 227
Boston 155
Hefei 147
Los Angeles 140
Nanjing 121
Dearborn 112
Santa Clara 98
Hong Kong 91
Helsinki 83
Dong Ket 80
Buffalo 78
Shanghai 71
Seoul 63
San Diego 61
New York 58
The Dalles 55
Redwood City 53
Padova 49
Shenyang 46
Ho Chi Minh City 45
Charleston 44
Guangzhou 42
São Paulo 41
Nanchang 38
Turin 36
Bari 35
Verona 35
Nuremberg 31
Toronto 31
London 30
Palermo 30
Sassari 29
Changsha 28
Florence 27
Hebei 27
Jiaxing 26
Redondo Beach 26
Council Bluffs 25
Naples 25
Norwalk 25
Washington 25
Frankfurt am Main 24
Munich 24
Hanoi 22
Tianjin 22
Bologna 21
Atlanta 20
Chicago 20
Orange 20
Stockholm 20
Jinan 19
Zhengzhou 19
Pune 18
Brooklyn 17
Auburn Hills 16
Ningbo 16
Warsaw 15
Genoa 14
Johannesburg 14
San Francisco 14
Brescia 13
Catania 13
Montreal 13
Perugia 13
Rio de Janeiro 13
Sydney 13
Columbus 12
Falls Church 12
Manchester 12
Messina 12
Parma 12
Phoenix 12
Torino 12
Brussels 11
Mexico City 11
Mountain View 11
Saint Petersburg 11
Tokyo 11
Denver 10
Hangzhou 10
Quito 10
Totale 110.057
Salva come PNG Salva come JPEG
Nome #
Child and Adolescent Behavior Inventory (CABI): Standardization for age 6-17 years and first clinical application 2.025
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 1.846
Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder 1.818
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate 1.671
Practitioner Review: Current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder 1.593
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine 1.587
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence 1.561
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale 1.538
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 1.487
Cognitive training for attention-deficit/hyperactivity disorder: Meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials 1.476
Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD) 1.455
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives 1.443
Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents 1.440
The Italian autism network (ITAN): A resource for molecular genetics and biomarker investigations 1.384
Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe 1.338
Effects of methylphenidate on height in ADHD children. The monitoring of bone age within the ADDUCE project 1.336
The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles 1.287
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder 1.269
Corrigendum: Child and adolescent behavior inventory (CABI): A new instrument for epidemiological studies and pre-clinical evaluation 1.260
Effects of long-term methylphenidate use on growth and blood pressure: Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 1.236
ADHD and hyperkinetic disorder 1.224
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group 1.212
Re-thinking treatment targets in child and adolescent psychiatry 1.191
null 1.154
Pediatric acute-onset neuropsychiatric syndrome: A data mining approach to a very specific constellation of clinical variables 1.100
Psychosocial risk factors for suicidality in children and adolescents 1.051
null 1.045
Methylphenidate long-term effects on psychiatric outcomes in a Sardinian ADHD population: preliminary results from the prospective ADDUCE project 993
null 980
CRS-R. Conners’ Rating Scales. Revised. Manuale 973
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 968
A neurodevelopment approach for a transitional model of early onset schizophrenia 933
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies 889
Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog” 872
Systematic Review and Meta-analysis: Screening Tools for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents 801
Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: A systematic review of head-to-head studies[ BMC Psychiatry. (2013)13, 237] 791
Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) 788
Prevalence and correlates of mental disorders among adolescents in Italy: The PrISMA Study 763
null 754
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 751
null 750
Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial 735
Unbalanced risk-benefit analysis of ADHD drugs – Authors' reply 706
null 699
Profili cognitivi e disturbi psicopatologici. Evidenze neurobiologiche, diagnosi, trattamento 698
null 689
null 675
null 665
Neuropsychological characterization of aggressive behavior in children and adolescents with cd/odd and effects of single doses of medications: The protocol of the matrics_wp6-1 study 660
null 658
Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis 657
The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG) 650
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children 646
null 632
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication? 631
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 625
The poor outcome of conduct disorders: a need for innovative, more effective therapeutic interventions 608
null 603
Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study 597
null 595
null 588
Increased Response-Time Variability Across Different Cognitive Tasks in Children With ADHD 585
null 581
null 581
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial 573
null 568
null 564
Eziologia 553
Clinical characteristics, neuroimaging findings, and neuropsychological functioning in attention-deficit hyperactivity disorder: Sex differences 552
null 549
A crucial role for basic emotion awareness in the development of emotion regulation? 542
Association of Risk of Suicide Attempts With Methylphenidate Treatment 540
Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project 539
The neuropsychological characterization of aggressive behaviour in children and adolescents with CD/ODD: preliminary results from a multicentric case-control study (MATRICS_consortium) 539
null 536
null 519
null 517
I Disturbi depressivi in età evolutiva 506
null 506
null 501
null 501
Use of atomoxetine in patients with attention-deficit hyperactivity disorder and comorbid conditions 500
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents 500
Management and treatment of attention-deficit/hyperactivity disorder 499
null 497
null 491
The MTA at 8 488
Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design 488
EFFICACY STUDY OF AN OMEGA-3/6 COMBINATION FOR MILD- TO MODERATE-INATTENTIVE ADHD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN ITALIAN CHILDREN 482
null 477
null 467
Non-pharmacological interventions for Attention-Deficit/Hyperactivity Disorder: Systematic review and meta-analyses of randomised controlled trials of dietary and psychological treatments 467
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review 467
European clinical guidelines for hyperkinetic disorder - first upgrade 465
Plasma poly-unsatured fatty acids profile in children with inattentive ADHD - preliminary results of an efficacy Italian study with omega 3/6 462
null 444
SRS Social Responsiveness Scale di John N. Constantino e Christian P. Grube 443
null 428
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. 420
Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder 413
Totale 82.800
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.826
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.522 0 0 0 0 0 1.867 1.869 953 511 590 483 1.249
2021/20227.717 573 518 324 892 763 432 371 602 813 872 740 817
2022/202314.499 1.096 1.876 1.615 1.101 1.067 1.151 670 1.949 962 856 1.497 659
2023/202416.961 829 681 632 1.058 1.953 2.626 2.791 1.014 844 1.224 1.784 1.525
2024/202533.367 5.755 8.871 5.369 4.342 2.223 1.915 1.670 232 420 1.380 581 609
2025/20263.709 678 333 998 776 851 73 0 0 0 0 0 0
Totale 117.964